Notably, CML patients on TKIs exhibit significant impairment of humoral IgM responses to pneumococcal vaccines compared with controls, which is likely due to a significant loss of peripheral blood IgM memory B-cells, whereas immune responses to influenza vaccination are comparable with controls [106]. This evidence concerns the gene CD40LG and chronic myelogenous leukemia, BCR-ABL1 positive.